Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1997 2
2002 2
2003 2
2005 1
2006 1
2007 1
2008 2
2009 3
2010 2
2011 1
2012 2
2013 3
2015 1
2017 3
2018 1
2019 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Dilated cardiomyopathy 1B"
Page 1
Arrhythmias in the muscular dystrophies.
Groh WJ. Groh WJ. Heart Rhythm. 2012 Nov;9(11):1890-5. doi: 10.1016/j.hrthm.2012.06.038. Epub 2012 Jun 30. Heart Rhythm. 2012. PMID: 22760083 Review.
Duchenne, Becker, and limb-girdle types 2C-2F and 2I are muscular dystrophies in which the development of a dilated cardiomyopathy is common. Arrhythmias and conduction disease occur after the development of the dilated cardiomyopathy. Patients are con …
Duchenne, Becker, and limb-girdle types 2C-2F and 2I are muscular dystrophies in which the development of a dilated cardiomyopathy
Dystrophies and heart disease.
Cox GF, Kunkel LM. Cox GF, et al. Curr Opin Cardiol. 1997 May;12(3):329-43. Curr Opin Cardiol. 1997. PMID: 9243091 Review.
The muscular dystrophies are a clinically and genetically heterogeneous group of skeletal muscle-wasting diseases that differ widely in their frequency and pattern of cardiac involvement. Myocardial disease manifesting predominantly as cardiomyopathy and congestive heart f …
The muscular dystrophies are a clinically and genetically heterogeneous group of skeletal muscle-wasting diseases that differ widely in thei …
Clinical, pathological, imaging, and genetic characterization in a Taiwanese cohort with limb-girdle muscular dystrophy.
Liang WC, Jong YJ, Wang CH, Wang CH, Tian X, Chen WZ, Kan TM, Minami N, Nishino I, Wong LC. Liang WC, et al. Orphanet J Rare Dis. 2020 Jun 23;15(1):160. doi: 10.1186/s13023-020-01445-1. Orphanet J Rare Dis. 2020. PMID: 32576226 Free PMC article.
On the basis of different pathological categories, we performed sequencing of target genes or panel for NMDs and then identified patients with type 1B, 1E, 2A, 2B, 2D, 2I, 2G, 2 N, and 2Q. The 1B patients with LMNA mutation presented with mild limb-girdle weakness b …
On the basis of different pathological categories, we performed sequencing of target genes or panel for NMDs and then identified patients wi …
Interferon beta-1b therapy in chronic viral dilated cardiomyopathy--is there a role for specific therapy?
Zimmermann O, Rodewald C, Radermacher M, Vetter M, Wiehe JM, Bienek-Ziolkowski M, Hombach V, Torzewski J. Zimmermann O, et al. J Card Fail. 2010 Apr;16(4):348-56. doi: 10.1016/j.cardfail.2009.12.016. Epub 2010 Feb 7. J Card Fail. 2010. PMID: 20350703
BACKGROUND: Myocardial biopsy can be used for the detection of viral genome in dilated cardiomyopathy (DCM). Pilot studies have previously reported beneficial effects on clinical outcome and safety of an antiviral therapy using interferon beta-1b in chronic v …
BACKGROUND: Myocardial biopsy can be used for the detection of viral genome in dilated cardiomyopathy (DCM). Pilot studies hav …
Predictors of disease progression in pediatric dilated cardiomyopathy.
Molina KM, Shrader P, Colan SD, Mital S, Margossian R, Sleeper LA, Shirali G, Barker P, Canter CE, Altmann K, Radojewski E, Tierney ES, Rychik J, Tani LY; Pediatric Heart Network Investigators. Molina KM, et al. Circ Heart Fail. 2013 Nov;6(6):1214-22. doi: 10.1161/CIRCHEARTFAILURE.113.000125. Epub 2013 Oct 16. Circ Heart Fail. 2013. PMID: 24132734 Free PMC article. Clinical Trial.
BACKGROUND: Despite medical advances, children with dilated cardiomyopathy (DCM) remain at high risk of death or need for cardiac transplantation. ...Patients requiring intravenous inotropic/mechanical support or listed status 1A/1B for transplant were exclud …
BACKGROUND: Despite medical advances, children with dilated cardiomyopathy (DCM) remain at high risk of death or need for card …
Urinary Proteomics in Predicting Heart Transplantation Outcomes (uPROPHET)-Rationale and database description.
Huang QF, Trenson S, Zhang ZY, Yang WY, Van Aelst L, Nkuipou-Kenfack E, Wei FF, Mujaj B, Thijs L, Ciarka A, Zoidakis J, Droogné W, Vlahou A, Janssens S, Vanhaecke J, Van Cleemput J, Staessen JA. Huang QF, et al. PLoS One. 2017 Sep 7;12(9):e0184443. doi: 10.1371/journal.pone.0184443. eCollection 2017. PLoS One. 2017. PMID: 28880921 Free PMC article.
RESULTS: Of 352 participants in the UP study (24.4% women), 38.9%, 40.3%, 5.7% and 15.1% had ischemic, dilated, hypertrophic or other cardiomyopathy. The median interval between HTx and first UP assessment (baseline) was 7.8 years. ...The TP study currently includes …
RESULTS: Of 352 participants in the UP study (24.4% women), 38.9%, 40.3%, 5.7% and 15.1% had ischemic, dilated, hypertrophic or other …
Matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, B+ tenascin-C and ED-A+ fibronectin in dilated cardiomyopathy: potential impact on disease progression and patients' prognosis.
Franz M, Berndt A, Neri D, Galler K, Grün K, Porrmann C, Reinbothe F, Mall G, Schlattmann P, Renner A, Figulla HR, Jung C, Küthe F. Franz M, et al. Int J Cardiol. 2013 Oct 15;168(6):5344-51. doi: 10.1016/j.ijcard.2013.08.005. Epub 2013 Aug 15. Int J Cardiol. 2013. PMID: 23998545
BACKGROUND: Dilated cardiomyopathy (DCM) is associated with heart failure and increased mortality and there is no reliable biomarker to estimate patients' prognosis. ...
BACKGROUND: Dilated cardiomyopathy (DCM) is associated with heart failure and increased mortality and there is no reliable bio …
Comparison of left ventricular systolic and diastolic function in patients with idiopathic dilated cardiomyopathy and mild heart failure versus those with severe heart failure.
Richartz BM, Werner GS, Ferrari M, Figulla HR. Richartz BM, et al. Am J Cardiol. 2002 Aug 15;90(4):390-4. doi: 10.1016/s0002-9149(02)02495-5. Am J Cardiol. 2002. PMID: 12161228 Clinical Trial.
The pathogenesis of acute pulmonary edema in idiopathic dilated cardiomyopathy (IDC) is not completely understood. Because pulse-wave tissue Doppler imaging (TDI) allows a direct comparison between systolic as well as diastolic wall motion velocities, we tested the …
The pathogenesis of acute pulmonary edema in idiopathic dilated cardiomyopathy (IDC) is not completely understood. Because pul …
Prognostic role of myocardial tumor necrosis factor-alpha and terminal complement complex expression in patients with dilated cardiomyopathy.
Zimmermann O, Kochs M, Zwaka TP, Bienek-Ziolkowski M, Höher M, Hombach V, Torzewski J. Zimmermann O, et al. Eur J Heart Fail. 2007 Jan;9(1):51-4. doi: 10.1016/j.ejheart.2006.04.001. Epub 2006 May 26. Eur J Heart Fail. 2007. PMID: 16730227 Free article.
BACKGROUND: In patients with dilated cardiomyopathy (DCM), elevated plasma levels of tumor necrosis factor-alpha (TNF-alpha) are associated with poor prognosis. ...Patients received conventional treatment of heart failure and, in a few cases, additional treatment wi …
BACKGROUND: In patients with dilated cardiomyopathy (DCM), elevated plasma levels of tumor necrosis factor-alpha (TNF-alpha) a …
Myocardial biopsy based classification and treatment in patients with dilated cardiomyopathy.
Zimmermann O, Kochs M, Zwaka TP, Kaya Z, Lepper PM, Bienek-Ziolkowski M, Hoher M, Hombach V, Torzewski J. Zimmermann O, et al. Int J Cardiol. 2005 Sep 15;104(1):92-100. doi: 10.1016/j.ijcard.2005.02.052. Int J Cardiol. 2005. PMID: 16137516
BACKGROUND: We investigated whether myocardial biopsy analysis for inflammation and viruses correlates with outcome in dilated cardiomyopathy. METHODS: Myocardial biopsies of 82 patients were analyzed for HLAI, HLAII, CD54, CD2, CD68 and entero-/adenovirus. ...Group …
BACKGROUND: We investigated whether myocardial biopsy analysis for inflammation and viruses correlates with outcome in dilated car
27 results